The CFX96 Dx Real-Time System joins other Bio-Rad products that are being used for the detection of COVID-19, including Bio-Rad's SARS-CoV-2 Droplet Digital PCR (ddPCR) ...

Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2025 investor ...

The renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $9.57 billion. Bio-Rad’s earnings surpassed estimates in ...

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

The renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $6.72 billion. Bio-Rad’s earnings surpassed estimates in ...

The CFX Opus Real-Time PCR System offers the reliability you depend on from Bio-Rad with improved thermal performance and an intuitive interface for your lab. Maximum ramp rate, °C/sec CFX Opus 96 ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Foresight™ Pro 45 cm inner diameter (ID) ...

$80,000 of BIO-RAD LABORATORIES lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to biomedical research ...

--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2025 ...